SCHEDULE 13D

Company

Lexaria Bioscience Corp.

Filed

September 18, 2023

Accession Number

0001987877-23-000002

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →